Legend Biotech Corp. (LEGN)
18.57
-0.75
(-3.88%)
USD |
NASDAQ |
Oct 02, 16:00
18.57
0.00 (0.00%)
After-Hours: 20:00
Legend Biotech Gross Profit Margin (Quarterly) : 61.52% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 61.52% |
| March 31, 2026 | 37.23% |
| December 31, 2025 | 55.80% |
| September 30, 2025 | 55.42% |
| June 30, 2025 | 59.29% |
| March 31, 2025 | 60.76% |
| December 31, 2024 | 56.72% |
| September 30, 2024 | 61.96% |
| June 30, 2024 | 70.07% |
| March 31, 2024 | 35.67% |
| December 31, 2023 | 52.43% |
| September 30, 2023 | 49.33% |
| June 30, 2023 | 55.45% |
| March 31, 2023 | 1.99% |
| Date | Value |
|---|---|
| December 31, 2022 | -2.10% |
| September 30, 2022 | 6.95% |
| June 30, 2022 | -41.50% |
| March 31, 2022 | 0.00% |
| December 31, 2021 | 0.00% |
| September 30, 2021 | 0.00% |
| June 30, 2021 | 0.00% |
| March 31, 2021 | |
| December 31, 2020 | 0.00% |
| September 30, 2020 | 0.00% |
| June 30, 2020 | 0.00% |
| March 31, 2020 | 0.00% |
| December 31, 2019 | 0.00% |
| September 30, 2019 | 0.00% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 79.81% |
| Ionis Pharmaceuticals, Inc. | 96.13% |
| Johnson & Johnson | 68.73% |
| Arbutus Biopharma Corp. | 98.92% |
| Capricor Therapeutics, Inc. | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -8.76% |
| Return on Assets | -5.42% |
| Return on Invested Capital | -6.45% |
| Profit Margin (Quarterly) | 8.57% |
| Operating Margin (Quarterly) | 14.89% |
| Return on Net Operating Assets | -21.87% |